By using the Ang II-induced murine model of aortic aneurysm, Jones et al. found that treatment with PPARγ agonist rosiglitazone had ameliorative effects on aneurysm development and rupture, which exerted a protective effect on aneurysm development and rupture [30]. The gene discussed is AGT; the disease is aneurysm.